Pfizer UK Recall for Sayana® Press (medroxyprogesterone acetate 104mg/0.65ml suspension for injection in the Uniject™ injection system)
File size 150KB | Date: 24 October 2019
The manufacturer of Sayana Press® yesterday issued a recall for a small number of batches.
Posted 24 October 2019
Date: 24 Oct 2019
Type: FSRH News and Information
Read more for which batches are affected.
Please check your stock and return affected batches to the original supplier.
Pfizer states that the problem with the affected batches relates to sealing of the Uniject™ injection device. They advise that use of the impacted product has an unlikely probability of being associated with adverse events and the potential risk to patients is considered to be negligible.
Any adverse reactions should be reported as usual via the Yellow Card Scheme.
You can access the statement below.
Related Documents